Skip to Main Content

Author Details

Miriam C J M Sturkenboom
University Medical Center Utrecht
1991
431
71
PMIDPaper TitleJournal TitlePublished Year
36417423COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.Br J Clin Pharmacol2023
37663263Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis.Front Pharmacol2023
37594175Variations across Europe in hospitalization and management of pregnant women with SARS-CoV-2 during the initial phase of the pandemic: Multi-national population-based cohort study using the International Network of Obstetric Survey Systems (INOSS).Acta Obstet Gynecol Scand2023
37024736Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose.Drug Saf2023
37445553Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020-2022: A Scoping Review.J Clin Med2023
37243964Authors' Reply to Juergen O Kirchner's Comment on "Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project".Drug Saf2023
37376424COVID-19 Vaccine Safety Monitoring Studies in Low- and Middle-Income Countries (LMICs)-A Systematic Review of Study Designs and Methods.Vaccines (Basel)2023
37370079Stimulating solidarity to improve knowledge on medications used during pregnancy : A contribution from the ConcePTION project.BMC Med Ethics2023
37198019Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.Vaccine2023
37294532Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.Drug Saf2023
34826340From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding.Clin Pharmacol Ther2022
35411472Correction to: A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project.Drug Saf2022
35436951A Learning Healthcare System for pregnant and breastfeeding women: what do women during preconception, pregnancy, and nursing think? - A qualitative study : A contribution from the ConcePTION project.BMC Pregnancy Childbirth2022
35357659A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project.Drug Saf2022
36506571Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries.Front Pharmacol2022
36258262Alignment of vaccine codes using an ontology of vaccine descriptions.J Biomed Semantics2022
35113648Rare Variation in Drug Metabolism and Long QT Genes and the Genetic Susceptibility to Acquired Long QT Syndrome.Circ Genom Precis Med2022
32911562The Certainty Framework for Assessing Real-World Data in Studies of Medical Product Safety and Effectiveness.Clin Pharmacol Ther2021
33846042The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.Vaccine2021
33658868Challenges Associated with the Safety Signal Detection Process for Medical Devices.Med Devices (Auckl)2021
34596623Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries.Pediatr Infect Dis J2021
34011501Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions.BMJ Glob Health2021
33462778Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project.Drug Saf2021
33355904Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors.Drug Saf2021
33293161How to ensure we can track and trace global use of COVID-19 vaccines?Vaccine2021
33000427Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe.Drug Saf2021
31617080Exploratory Study of Signals for Asthma Drugs in Children, Using the EudraVigilance Database of Spontaneous Reports.Drug Saf2020
32061385ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations.Vaccine2020
31937606Big Data in the Assessment of Pediatric Medication Safety.Pediatrics2020
31876615Systematic Review and Meta-analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events.Pediatr Infect Dis J2020
32025756Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.Osteoporos Int2020
31696274Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.Osteoporos Int2020
31677953ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example.Vaccine2020
31677952Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.Vaccine2020
31677951ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.Vaccine2020
31677950Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.Vaccine2020
31677949Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination.Vaccine2020
31677947ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.Vaccine2020
31677946ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.Vaccine2020
33051958Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands.Pharmacoepidemiol Drug Saf2020
33301495Vaccines safety and maternal knowledge for enhanced maternal immunization acceptability in rural Uganda: A qualitative study approach.PLoS One2020
32757044Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance.Osteoporos Int2020
32954855Blockchain technology applications to postmarket surveillance of medical devices.Expert Rev Med Devices2020
32280043ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data.Vaccine2020
32308179'Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study'.Epidemiol Psychiatr Sci2020
32115766Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study.Pediatr Allergy Immunol2020
32243569Different Strategies to Execute Multi-Database Studies for Medicines Surveillance in Real-World Setting: A Reflection on the European Model.Clin Pharmacol Ther2020
32147297Fatal outcomes following immunization errors as reported to the EudraVigilance: A case series.Vaccine2020
32174450Multinational cohort study of mortality in patients with asthma and severe asthma.Respir Med2020
32171573Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.Vaccine2020
  • 1 - 50 of 431

Recommended Authors

Institute for Medical Biostatistics, University Medical Center Mainz
Career Start Year 2013
Number of shared co-authors 3
The University of Manchester, University of Manchester
Career Start Year 2013
Number of shared co-authors 7
Mayo Clinic
Career Start Year 2011
Number of shared co-authors 0
Janssen Pharmaceutical Research and Development
Career Start Year 2010
Number of shared co-authors 12
Stanford University
Career Start Year 2010
Number of shared co-authors 8
Bayer Pharmaceuticals
Career Start Year 2010
Number of shared co-authors 9
RTI Health Solutions
Career Start Year 2009
Number of shared co-authors 10
Bayer Pharma AG
Career Start Year 2009
Number of shared co-authors 1
University of Toronto
Career Start Year 2007
Number of shared co-authors 5
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 5
Ben Gurion University
Career Start Year 2003
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 2
Center for Primary and Community Care, University of Lucerne
Career Start Year 1998
Number of shared co-authors 0
Kaiser Permanente Washington Health Research Institute
Career Start Year 1998
Number of shared co-authors 9
University of Dundee
Career Start Year 1996
Number of shared co-authors 12
Rush University Medical Center
Career Start Year 1995
Number of shared co-authors 3
Stanford University
Career Start Year 1994
Number of shared co-authors 8
University Health Network
Career Start Year 1994
Number of shared co-authors 0
Institute of Applied Health Research, University of Birmingham
Career Start Year 1991
Number of shared co-authors 2
Institute of Social and Preventive Medicine, University of Bern
Career Start Year 1990
Number of shared co-authors 0
Columbia University.
Career Start Year 1990
Number of shared co-authors 7
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1990
Number of shared co-authors 1
Center for Drug Evaluation and Research
Career Start Year 1989
Number of shared co-authors 10
University of Bristol
Career Start Year 1988
Number of shared co-authors 3
Rutgers University School of Public Health
Career Start Year 1988
Number of shared co-authors 7
Institute of Health Policy, University of Toronto
Career Start Year 1984
Number of shared co-authors 4
Vanderbilt University Medical Center
Career Start Year 1982
Number of shared co-authors 5
School of Pharmacy, University of Washington
Career Start Year 1980
Number of shared co-authors 2
Harvard T.H. Chan School of Public Health
Career Start Year 1975
Number of shared co-authors 10

Collaborators

Co-authored papers 60
Erasmus Medical Center
Co-authored papers 51
University of California los angeles
Co-authored papers 42
Erasmus MC - University Medical Center Rotterdam
Co-authored papers 18
Harvard T.H. Chan School of Public Health
Co-authored papers 16
Erasmus University Medical Center
Co-authored papers 15
Co-authored papers 12
Harvard Medical School
Co-authored papers 10
Erasmus University Medical Centre
Co-authored papers 10
Erasmus University Medical Center
Co-authored papers 9
Co-authored papers 7
University of Oxford
Co-authored papers 5
Erasmus University Medical Center
Co-authored papers 5
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 4
University of Oxford
Co-authored papers 4
BC Children's Hospital Research Institute
Co-authored papers 3
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Co-authored papers 3
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 3
Leiden University Medical Center
Co-authored papers 3
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3
Erasmus University Medical Center
Co-authored papers 3
The University of Hong Kong
Co-authored papers 3
Instituto Carlos III
Co-authored papers 3
Erasmus University Medical Center
Co-authored papers 3
University of Aveiro
Co-authored papers 2
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Co-authored papers 2
University of Amsterdam, Cancer Center Amsterdam
Co-authored papers 2
university of massachusetts amherst Chan Medical School
Co-authored papers 2
Co-authored papers 2
Leiden University Medical Center
Co-authored papers 2